謝 政毅

Medicine & Life Sciences

1. Adjuvant Chemotherapy 50%
2. Aftercare 58%
3. Ambulatory Care 8%
4. Apoptosis 30%
5. Artificial Respiration 7%
6. Breast 6%
7. Breast Neoplasms 64%
8. Cancer Survivors 54%
9. Cell Membrane 5%
10. Cell Movement 17%
11. Cellular Apoptosis Susceptibility Protein 100%
12. Cohort Studies 5%
13. Colectomy 5%
14. Colonic Neoplasms 45%
15. Continuity of Patient Care 58%
16. Data Analysis 6%
17. Databases 8%
18. Drug Therapy 8%
19. Fluorescence 5%
20. Glutathione Transferase 7%
21. Health 8%
22. Heart Massage 5%
23. Hospital Emergency Service 13%
24. Hospitalization 12%
25. Immunoprecipitation 6%
26. Intubation 7%
27. Kaplan-Meier Estimate 5%
28. Mammography 8%
29. Margins of Excision 5%
30. MCF-7 Cells 15%
31. Microtubule-Associated Proteins 8%
32. Microtubules 20%
33. National Health Programs 5%
34. Neoplasms 30%
35. Nutritional Support 22%
36. Oncologists 25%
37. Physicians 31%
38. Population 19%
39. Propensity Score 8%
40. Proteins 5%
41. Pseudopodia 8%
42. Recurrence 5%
43. Retrospective Studies 5%
44. Taiwan 49%
45. Terminally Ill 65%
46. Therapeutics 12%
47. Tubulin 53%
48. tyrosine-tubulin 13%